Metafolin ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 201 | Angelman syndrome | 1 |
201. Angelman syndrome
Clinical trials : 25 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 22 - Drug target pathways : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00348933 (ClinicalTrials.gov) | July 2006 | 3/7/2006 | Dietary Supplements for the Treatment of Angelman Syndrome | Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome | Angelman Syndrome;Nervous System Diseases | Drug: Betaine;Drug: Creatine;Drug: Metafolin;Drug: Vitamin B12 | University of California, San Diego | Baylor College of Medicine;Rady Children's Hospital, San Diego;Boston Children’s Hospital;Greenwood Genetic Center;Rare Diseases Clinical Research Network | Completed | N/A | 5 Years | All | 90 | N/A | United States |